763-24-4-021-1611 & 763-24-4-021-1625 - Lancaster CMOP 3M #5050 Skin Protectant & RESERVOIR, OMNIPOD 5
ID: 36C77024Q0410Type: Solicitation
AwardedSep 26, 2024
$541.6K$541,648
AwardeeRIVERSIDE HOME MEDICAL SUPPLY INC Dallas TX 75220 USA
Award #:36C77024P0417
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/e634b097764e4fd4a0f0f6a63ffc60b0/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of specific medical supplies, namely the Cavilon Advanced Skin Protectant (3M#5050) and the Omnipod 5 G6 Reservoir, for the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP). This procurement is critical for patient care, as these items have been prescribed by VA physicians and are essential for the treatment of veterans, with no acceptable substitutes available. The contract will be awarded under Simplified Acquisition Procedures, with a firm-fixed-price structure and a requirement for staggered monthly deliveries, starting within 10 days of contract award. Interested vendors must submit their proposals by September 20, 2024, at 4 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.

    Point(s) of Contact
    Jennifer L Knight
    (913) 684-0162
    jennifer.knight@va.gov
    Files
    Title
    Posted
    S02_JnA_Q0410_allsigned.pdf
    The Department of Veterans Affairs (VA) is procuring specific medical/surgical supplies under Simplified Acquisition Procedures (FAR 13.5). The items include the Cavilon Advanced Skin Protectant (3M#5050) and Omnipod 5 G6 Reservoir (MPN: 08508-3000-21) through a sole-source justification, which permits limited competition due to the unique qualifications of the required products. These items are integral to patient care, having been prescribed by VA physicians, and substitutions are not allowed due to their specific medical necessity. The procurement action will result in a firm-fixed-price contract with planned monthly deliveries. Market research indicates that there are no equivalent alternatives available, and both products are made in the USA, negating the need for a Buy American Act (BAA) waiver. The Contracting Officer assures that the anticipated costs are fair and reasonable based on historical pricing and competitive practices. No new small business manufacturers were identified that could comply with procurement requirements, reinforcing the decision for sole-source acquisition. The procurement aims to meet critical medical needs for veterans efficiently and effectively while ensuring compliance with federal regulations.
    S02_Pricing_Schedule_Q0410.xlsx
    The document outlines a Request for Quotation (RFQ) for medical supplies by the VA, specifically detailing requirements for two items: a skin protectant and a device reservoir. Vendors are instructed to fill in specific areas and provide quotes for bids, compliant with the Buy American Act. The RFQ specifies delivery schedules—100 cases per month for six months of skin protectant and 350 boxes per month for four months for the reservoir. Vendors must ensure the expiration dates of all items delivered are no less than one year from the delivery date. Required documentation includes a signed solicitation cover page (SF1449), an Excel quote spreadsheet detailing the country of origin, a BAA certificate for non-domestic items, and proof of authorized dealership for the listed products. The proposal submission deadline is September 20, 2024, by 4 PM CST, and quotes must be emailed to the designated contact. This RFQ emphasizes adherence to regulatory requirements while aiming to secure vital medical supplies efficiently and reliably for government use.
    S02_RFQ_36C77024Q0410___.pdf
    The document outlines a Request for Quotation (RFQ) from the Department of Veterans Affairs, specifically for the procurement of medical supplies for the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP). It details the requirements for two specific items: a Skin Protectant (Cavilon Advanced 3M#5050) and a reservoir for the Omnipod 5 G6 (Insulet Corp). The RFQ emphasizes the necessity for compliance with various regulations, including the Buy American Act and stipulates detailed packaging, labeling, and delivery processes. Proposals must adhere to strict timelines, including staggered monthly deliveries for both items, with initial shipments required within 10 days after the awarded contract. Vendors must ensure that products are shippable via USPS and include bar coding that meets specified quality standards. The document also outlines invoicing procedures, indicating that electronic submission is preferred, and highlights the importance of prior approval for any modifications or substitutions. Overall, the RFQ is structured to ensure compliance with federal acquisition regulations, facilitate efficient procurement processes, and guarantee the quality and reliability of supplies for the VA healthcare system.
    S03_Pre_Sol_36C77024Q0410.pdf
    The Department of Veterans Affairs (VA) Network Contracting Office 15 is planning to procure two medical supplies: the 3M #5050 Skin Protectant and the Omnipod 5 Reservoir. The solicitation number is 36C77024Q0410, with a response due by September 20, 2024, at 4 PM Central Time. The procurement is categorized as "Full and Open" under Product Service Code 6515 and NAICS Code 325413. Requirements include monthly deliveries: 100 cases of skin protectant for six months and 350 boxes of reservoirs for four months, both starting 10 days after the contract award. Interested vendors must submit their proposals via email and include documentation like the SF1449 solicitation cover page, pricing schedule, and certificates as per the Buy American Act. Additionally, specific requirements for each line item include OEM authorization for the skin protectant and state wholesale distributor licenses for the reservoirs. The document underscores strict compliance with submission instructions and registration in SAM.gov, reflecting the VA's commitment to diligence in its procurement processes.
    Similar Opportunities
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    VA Direct to Patient supply services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to provide direct delivery supply services for medical and surgical items to Veteran patients through its Consolidated Mail Outpatient Pharmacy (CMOP) program. The contractor must demonstrate at least two years of experience, the capacity to process approximately 14 million prescriptions annually, and the ability to maintain compliance with federal and state regulations while ensuring a 48-hour average turnaround time for prescription fulfillment. This opportunity is critical for ensuring timely access to essential medical supplies for Veterans, with the contract structured to reimburse vendors per filled prescription at government contract prices, plus handling fees. Interested vendors must submit a capabilities statement to the primary contact, Phillip Reuwer, at Phillip.Reuwer@va.gov by January 11, 2026, with any questions directed to the same contact before January 8, 2026.
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for operational and mailing supplies to support seven Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. The procurement includes a wide range of items such as resealable bags, corrugated boxes, various types of mailers, child-resistant medical pouches, and packaging materials, all of which must adhere to specific material and postal regulations. This contract is crucial for ensuring the efficient operation of CMOP facilities, which play a vital role in delivering medications to veterans. Interested parties should contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov for further details, and must review the attached documents, including the pricing schedule and past performance requirements, as submissions are due by the specified deadlines.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6515--550-26-1-985-0034 InstyMed Dispenser System (VA-26-00024776)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to negotiate a limited source contract with InstyMeds for the procurement of an InstyMed Dispenser System, specifically for use at the Danville VA Medical Center and various Community-Based Outpatient Clinics (CBOCs). The VA requires four InstyMed Medication Dispensing Systems to enhance the efficiency of medication delivery from provider orders to patients, ensuring timely access to medications. This automated system is critical for pharmacy operations, offering features such as location-specific formulary management, real-time inventory tracking, and integration capabilities with existing systems like Vista, with potential for future compatibility with Cerner. For further inquiries, interested parties can contact Vernise L. Newton at vernise.newton@va.gov or by phone at 414-844-4800 x43248.